Biodexa Pharmaceuticals Plc (BDRX)
3.41
+0.16
(+4.92%)
USD |
NASDAQ |
Apr 15, 16:00
3.35
-0.06
(-1.76%)
After-Hours: 20:00
Biodexa Pharmaceuticals Research and Development Expense (Annual) : 5.026M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| NuCana Plc | 16.79M |
| Mereo BioPharma Group Plc | 17.81M |
| Bicycle Therapeutics Plc | 275.85M |
| Autolus Therapeutics Plc | 128.59M |
| GSK Plc | 8.171B |